Benefits of D-005, a lipid extract from Acrocomia crispa fruits, in the prevention of acute kidney njury induced by nephrotoxicity in rats.
Journal
Jornal brasileiro de nefrologia
ISSN: 2175-8239
Titre abrégé: J Bras Nefrol
Pays: Brazil
ID NLM: 9426946
Informations de publication
Date de publication:
Historique:
received:
01
03
2021
accepted:
12
05
2021
pubmed:
22
7
2021
medline:
24
3
2022
entrez:
21
7
2021
Statut:
ppublish
Résumé
Aminoglycoside-induced acute kidney injury (AKI) is a pathology closely linked to oxidative and inflammatory reactions. Taking into account the previous reported antioxidant and anti-inflammatory effects of D-005, a lipid extract obtained from Cuban palm Acrocomia crispa (Arecaceae) fruits, this work aimed to evaluate the effects of D-005 on kanamycin-induced AKI. Male Wistar rats were divided into 7 groups: negative control (vehicle, Tween 65/H2O) and six groups treated with kanamycin to induce AKI: positive control (vehicle), D-005 (25, 100, 200, and 400 mg/kg) and grape seed extract (GSE, 200 mg/kg). D-005, vehicle, and GSE oral treatments were administered once daily for seven days, 1 h before kanamycin (500 mg/kg, i.p.). Serum uric acid and urea concentrations, renal histopathology, and oxidative markers (malondialdehyde (MDA), sulfhydryl (SH) groups, and catalase (CAT) activity) were assessed. D-005 significantly reduced uric acid and urea levels, starting from D-005 100 mg/kg. Histopathologically, D-005, at all the tested doses, protected renal parenchyma structures (glomeruli, proximal tubules, and interstitium). These findings were accompanied by a significant reduction of MDA and SH group concentrations as well as restoration of CAT activity. The highest percentages of inhibition were obtained with the dose of 400 mg/kg. GSE, the reference substance, also prevented kanamycin-induced biochemical and histopathological changes, as well as reduced MDA and SH groups and restored CAT activity. The administration of repeated oral doses of D-005 significantly protected against kanamycin-induced AKI, which could be associated with the antioxidant and anti-inflammatory effects of this extract.
Identifiants
pubmed: 34289007
pii: S0101-28002021005058301
doi: 10.1590/2175-8239-JBN-2021-0048
pmc: PMC8943882
pii:
doi:
Substances chimiques
Antioxidants
0
Lipids
0
Uric Acid
268B43MJ25
Malondialdehyde
4Y8F71G49Q
Types de publication
Journal Article
Langues
eng
por
Sous-ensembles de citation
IM
Pagination
9-18Références
Kidney Int. 2011 Jan;79(1):33-45
pubmed: 20861826
Integr Biol (Camb). 2011 Sep;3(9):879-86
pubmed: 21799993
Ren Fail. 2012;34(2):227-34
pubmed: 22263836
Anal Biochem. 1978 Jun 15;87(1):206-10
pubmed: 98070
Biomed Pharmacother. 2017 Jan;85:128-135
pubmed: 27930976
Zool Res. 2018 Mar 18;39(2):72-86
pubmed: 29515089
Toxicology. 2017 Jun 15;385:10-17
pubmed: 28472626
Kidney Res Clin Pract. 2019 Dec 31;38(4):462-471
pubmed: 31826388
Expert Opin Drug Saf. 2020 Feb;19(2):167-186
pubmed: 31914328
Ren Fail. 2011;33(8):824-32
pubmed: 21787152
Nutrients. 2017 Jul 07;9(7):
pubmed: 28686196
Pharmacology. 2003 Mar;67(3):118-20
pubmed: 12571406
J Bras Nefrol. 2020 Jul-Sep;42(3):290-299
pubmed: 32720969
Biomed Res Int. 2017;2017:5605634
pubmed: 28744467
Iran J Kidney Dis. 2019 Jan;13(1):10-20
pubmed: 30851714
Anal Biochem. 1979 Jun;95(2):351-8
pubmed: 36810
Mol Med Rep. 2014 Mar;9(3):801-7
pubmed: 24399449
Toxicology. 2017 Feb 15;377:14-24
pubmed: 27940129
Naunyn Schmiedebergs Arch Pharmacol. 2015 Dec;388(12):1305-15
pubmed: 26272642
Bratisl Lek Listy. 2017;118(4):233-242
pubmed: 28471235
Res Exp Med (Berl). 2000 Feb;199(4):195-206
pubmed: 10743677
J Am Soc Nephrol. 2015 Aug;26(8):1765-76
pubmed: 25810494
Clin Kidney J. 2016 Feb;9(1):48-50
pubmed: 26798460
Cell Mol Biol (Noisy-le-grand). 2018 Nov 30;64(14):108-113
pubmed: 30511629
Acta Med Iran. 2013;51(12):871-8
pubmed: 24442542
EXCLI J. 2017 Mar 24;16:388-399
pubmed: 28507482
Nat Rev Nephrol. 2017 Apr;13(4):241-257
pubmed: 28239173
Basic Clin Pharmacol Toxicol. 2006 Sep;99(3):230-6
pubmed: 16930296
Methods Enzymol. 1994;233:380-5
pubmed: 8015473